Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001075632 | SCV001241259 | likely pathogenic | Retinal dystrophy | 2019-02-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001247031 | SCV001420428 | pathogenic | not provided | 2024-03-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Thr2465Tyrfs*12) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of retinitis pigmentosa ‚Äã (PMID: 32218477). ClinVar contains an entry for this variant (Variation ID: 867095). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003462633 | SCV004193545 | pathogenic | Retinitis pigmentosa 25 | 2024-03-03 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV001075632 | SCV004707441 | pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research |